Sangamo Therapeutics, Inc. (FRA:GBY)
0.3601
+0.0351 (10.80%)
At close: Jan 5, 2026
Sangamo Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence. Standard template. Financial Sources.